Drugs have been used for recreational purposes since time immemorial. Addicting potential and the propensity to harm has led to a ban on many of these drugs. New compounds are being developed to circumvent the ban. They are similar in effect to the banned drugs but are slightly different in their chemical structure so that they can escape detection in the standard drug tests. These drugs are commonly known as designer drugs or new psychoactive substances (NPS).This work aimed to do a comprehensive review on chemistry, pharmacology and toxicology of new designer drugs for establishing the basic knowledge about them, focusing on their assessment and management and recent methods for their detection.According to the United Nations Office on Drugs and Crime (UNODC) classification, NPS include the following groups: Synthetic cannabinoids, synthetic cathinones, piperazine, phenethylamines, ketamine analogues, plant-based substances(Kratom, Salvia Divinorum) and miscellaneous substances (aminoindanes and tryptamines). NPS have become a global phenomenon with over 100 countries and territories from all regions of the world having reported one or more NPS. Up to December 2015, more than 600 substances have been reported to the UNODC Early Warning Advisory (EWA) on NPS by Governments, laboratories and partner organizations.NPS represent a challenge both in forensic analytical toxicology as well as in clinical toxicology as they may cause serious toxicity and can escape detection in the standard drug tests.Clinicians should keep designer drugs in mind when evaluating substance use in young adults or in anyone presenting with acute neuropsychiatric complaintsCoordination among emergency medical personnel, forensic toxicologists, scientific researchers, law enforcement and policymakers is essential to foster more effective responses in dealing with this evolving drug-abuse phenomenon.
Introduction
The term 'designer drugs' had been traditionally used to identify synthetic substances but has recently been broadened to include other psychoactive substances that mimic the effects of illicit drugs. They are produced by introducing slight modifications to the chemical structure of controlled substances to circumvent drug controls (UNODC, 2013a).
The majority of new recreational designer drugs can be described by their effects as hallucinogenic, stimulant, opioid-like and they may have a combination of these effects. New designer drugs as compared to traditional drugs of abuse are cheap, easy to obtain and not detectable by standard toxicology screens. They are generally marked with disingenuous labels such as "not for human Hend G. Aref 206 consumption", "herbal incense"," Spice" and "bath salts" to avoid drug control measures (Spaderna et al., 2013).Designer drugs have many concepts as research chemicals, legal highs, synthetic legal intoxicating drugs, novel psychoactive substances and NPS. The concept of "NPS" is the latest concept. The use of the term "new "does not refer to the time when a substance was first identified or synthesized, but to when it emerged in the global market for recreational use (UNODC, 2013a and UNODC, 2013b). Aim of the work As a result of increasing the number of designer drugs on the market, a comprehensive review on its chemistry, pharmacology and toxicology is required for 1. Introducing and establishing the basic knowledge about these new designer drugs for further researches 2. Focusing on their assessment and management 3. Exploring recent advances in analytical toxicology methods for their detection.
Historical background of designer drugs
Until the last third of the 20th century, drugs were either wholly natural (e.g., marijuana) or were processed products that had their origins in natural substances. For example, cocaine was produced from the coca plant, heroin from opium poppies and wine from fermented grapes. (Carpenter, 2015) 
Global emergence of New Psychoactive Substances
The UNODC questionnaire on NPS received more than 240 responses from 80 countries and territories, indicating a high level of interest. All NPS groups have emerged in all regions, except Africa where, so far, no synthetic cathinones and phenethylamines have been reported (Fig, 1) SCs exert their effects by binding to CB1 and CB2 receptors like THC. CBRs are Gprotein coupled receptors for which activation results in presynaptic hyperpolarization through changes in calcium influx and potassium efflux, resulting in neuronal hyperpolarization and a decrease in neurotransmitter release.They are used by oral and inhalational routes. Clinical case reports of intoxicated patients with SCs describe a variety of somatic and neuropsychiatric effects.The most prevalent side effects include tachycardia, hypertension, hyperthermia, tremors, ataxia, agitation, paranoia, delusions, anxiety, vomiting,conjunctival injection, rhabdomyolysis and acute renal failure.Case reports of Spice tolerance, withdrawal and drug dependence have described (Gurney et et al., 2014) . Multiple deaths reported in by international media and the medical literature have been linked to bath salt products indicating the urgent need to raise awareness and educate the public and medical communities on this topic (Rosenbaum et al., 2012) . They are closely related to amphetamines, the difference being the ketone group introduced at the β-position of the amino alkyl chain attached to the phenyl ring so, they are called β-keto-amphetamines (Fig,4) . 
Piperazine derived designer drugs:
The basic molecule of this group is piperazine that was first introduced in medicine in 1953, for its anthelminthic properties. Piperazine derivatives (PZDs) have emerged as a new group of recreational drugs over the last decade. They are sought to be used for their amphetamine like effects (Arbo et al., 2012) Chemically, the backbone of PZDs is the piperazine moiety attached to an aromatic group (Fig,5) .They are divided into two classes,benzyl-piperazinesas BZP (1-benzylpiperazine)and phenyl-piperazines as mCPP (1-(3-chlorophenyl) piperazine) and MeOPP (1-(4-methoxyphenyl)piperazine) (Arbo et al., 2012) . 
Figure (5):

Plant-based substances:
• Salvia divinorum Salvia divinorum is a naturally occurring herb that has been used in Mexico for centuries. It is administered via chewing or smoking routes. Its desired effects include a state of "trance" that is similar to that produced by ketamine and cannabis. Effects of salvia intoxication include anxiety, dysphoria, confusion, language impairments and fear associated with "bad trips". Cases of addiction have been reported but its prevalence has not been studied(Rosenbaum et al., 2012 and UNODC, 2013a).
• Kratom (Mitragynaspeciosa) Kratom is a tree found in tropical and subtropical regions of South East Asia. The fresh leaves are chewed while the powder form is brewed into tea. It has opium-like effect. It was also used as a in traditional medicine for common illnesses such as coughing, diarrhea, muscle pain and to cure morphine addicts as it is effective in relieving opiate withdrawal symptoms. However, its use as a NPS in the global market has been recently reported Heavy use can lead to adverse effects as seizures, profound sedation, nausea, vomiting and tremors (UNODC, 2013a).
Miscellaneous substances:
Miscellaneous group of NPS is not commonly used and include aminoindanes and tryptamines.Aminoindanes have been sold as NPS for their ability to produce effects similar to MDMA. They are commonly found in powder form and crystals. The use of tryptamines increased over the past five years. Synthetic tryptamines as alphamethyltryptamine (AMT) produce hallucinogenic effects in humans due to the structural similarities between these tryptamines and some naturally occurring hallucinogenic tryptamines as psilocybin and psilocin. • Measures against the role of internet in distribution of NPS must be taken.
• Newly developed analytical methods for detecting NPS must be made widely available to assist in identifying novel substances as they emerge in the recreational drug market rapidly.
• Controlling the influx of NPS from overseas laboratories is a complex political and economic issue which will need international cooperation. .
